Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

The first full year of the post-COVID-pandemic era was characterized in the United States by continued economic recovery, persistently high ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

The freeze also prohibited the publication of scientific studies and research reports, including the CDC’s Morbidity and Mortality Weekly Report. KFF Health News reported that – until now – the ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic. If the settlement is finalized, it will ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Aims to revolutionize pharmaceutical manufacturing with focus on advanced aseptic processing technology.

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...